Audible. Prime Member exclusive offer. First 3 months free, $14.95 a month after 3 months. Cancel anytime. Offer ends July 31, 2024, 11:59 PM PT. Get this deal

Alzheimer Disease Blood Biomarkers
Jul 28 2024
Length: 15 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to Cart failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Please try again

Unfollow podcast failed

Please try again

Alzheimer Disease Blood Biomarkers

Listen for free

View show details

Summary
Biomarkers for Alzheimer disease (AD) provide insight into disease processes and may aid clinical diagnosis for individuals with cognitive impairment. Author Stephen Salloway, MD, MS, of Brown University joins JAMA Deputy Editor Christopher Muth, MD, to discuss 2 articles and an accompanying editorial about blood biomarkers for AD and potential implications for clinical practice.

Related Content:

Are Blood Tests for Alzheimer Disease Ready for Prime Time?
Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care
Changes in Alzheimer Disease Blood Biomarkers and Associations With Incident All-Cause Dementia
Show more Show less

Physical Illness & Disease Hygiene & Healthy Living Science

Show more Show less

What listeners say about Alzheimer Disease Blood Biomarkers

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon